Ultraprocessed Food Increases Risk for Death With Type 2 Diabetes

WEDNESDAY, Aug. 2, 2023 (HealthDay News) -- Higher consumption of ultraprocessed food (UPF) is associated with lower survival and higher cardiovascular mortality in patients with type 2 diabetes, according to a study published online July 26 in the American Journal of Clinical Nutrition.
Marialaura Bonaccio, Ph.D., from the IRCCS Istituto Neurologico Mediterraneo Neuromed in Pozzilli, Italy, and colleagues evaluated the association of UPF intake with all-cause and cardiovascular disease (CVD) mortality among 1,065 participants with type 2 diabetes followed for a median of 11.6 years.
The researchers found that greater UPF intake (quartile 4: ≥10.5 percent of total food eaten for women and ≥9 percent for men) versus the lowest (quartile 1: UPF <4.7 and <3.7 percent for women and men, respectively), was associated with a higher risk for both all-cause (hazard ratio, 1.70) and CVD mortality (hazard ratio, 2.64). Associations were not substantially changed with inclusion of the Mediterranean diet score in the model (hazard ratios, 1.64 and 2.55 for all-cause and CVD mortality, respectively). There was a linear dose-response relationship observed between UPF intake with both all-cause and CVD mortality.
"Besides prioritizing the adoption of a diet based on nutritional requirements, dietary guidelines for the management of type 2 diabetes should also recommend limiting UPF," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Dexamethasone Compared to Burr-Hole Drainage for Chronic Subdural Hematoma
THURSDAY, June 15, 2023 (HealthDay News) -- For patients with chronic subdural...
Neuropsychiatric Manifestations Seen in Monkeypox Patients
THURSDAY, Sept. 22, 2022 (HealthDay News) -- Neuropsychiatric presentations,...
How Does Your State Rank for Health Care?
THURSDAY, June 22, 2023 (HealthDay News) -- Folks living in Massachusetts,...
Drug Decriminalization Not Tied to Change in Fatal Drug Overdose Rates
FRIDAY, Sept. 29, 2023 (HealthDay News) -- There is no evidence of an...